Press releases
- Paragon 28 to Present at the Bank of America Securities 2024 Healthcare Conference
- Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024
- Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System
- Paragon 28 Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Net Revenue Guidance
- Paragon 28 to Present at the CG 2024 Musculoskeletal Conference
- Paragon 28 To Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 82.91m |
Free float | 49.83m |
P/E (TTM) | -- |
Market cap | 873.00m USD |
EPS (TTM) | -0.5819 USD |
--
More ▼